Physician profile

Christopher M Bean

Pediatric Urology · Jackson, MS

NPI 1568658458

$419.61

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$66.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Palette Life Sciences, INC. $197.63 2019-2020
Boston Scientific Corporation $101.52 2019
Coloplast Corp $36.79 2022-2024
Abbvie INC. $31.26 2024
180 Medical, INC. $22.97 2019
Alnylam Pharmaceuticals INC. $16.09 2023 Oxlumo
Rochester Medical Corporation $13.35 2021

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher M Bean

$419.61

in general payments reported 2019-2025

Years
2019-2024
Top company
Palette Life Sciences, INC.

https://glasscript.com/doctor/977770/christopher-m-bean

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.